HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.

Abstract
Drug resistance in epithelial ovarian cancer (EOC) is reportedly attributed to the existence of cancer stem cells (CSC), because in most cancers, CSCs still remain after chemotherapy. To overcome this limitation, novel therapeutic strategies are required to prevent cancer recurrence and chemotherapy-resistant cancers by targeting cancer stem cells (CSCs). We screened an FDA-approved compound library and found four voltage-gated calcium channel blockers (manidipine, lacidipine, benidipine, and lomerizine) that target ovarian CSCs. Four calcium channel blockers (CCBs) decreased sphere formation, viability, and proliferation, and induced apoptosis in ovarian CSCs. CCBs destroyed stemness and inhibited the AKT and ERK signaling pathway in ovarian CSCs. Among calcium channel subunit genes, three L- and T-type calcium channel genes were overexpressed in ovarian CSCs, and downregulation of calcium channel genes reduced the stem-cell-like properties of ovarian CSCs. Expressions of these three genes are negatively correlated with the survival rate of patient groups. In combination therapy with cisplatin, synergistic effect was shown in inhibiting the viability and proliferation of ovarian CSCs. Moreover, combinatorial usage of manidipine and paclitaxel showed enhanced effect in ovarian CSCs xenograft mouse models. Our results suggested that four CCBs may be potential therapeutic drugs for preventing ovarian cancer recurrence.
AuthorsHeejin Lee, Jun Woo Kim, Dae Kyung Kim, Dong Kyu Choi, Seul Lee, Ji Hoon Yu, Oh-Bin Kwon, Jungsul Lee, Dong-Seok Lee, Jae Ho Kim, Sang-Hyun Min
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 7 (Mar 27 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32230901 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Calcium Channels
  • Dihydropyridines
  • Nitrobenzenes
  • Piperazines
  • lacidipine
  • benidipine
  • manidipine
  • lomerizine
  • Paclitaxel
  • Cisplatin
Topics
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Apoptosis (drug effects)
  • Calcium Channel Blockers (pharmacology)
  • Calcium Channels (drug effects, metabolism)
  • Carcinoma, Ovarian Epithelial
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Cisplatin (pharmacology)
  • Dihydropyridines (pharmacology)
  • Drug Repositioning
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Neoplastic Stem Cells (drug effects, metabolism)
  • Nitrobenzenes
  • Ovarian Neoplasms
  • Paclitaxel (pharmacology)
  • Piperazines (pharmacology)
  • Signal Transduction (drug effects, genetics)
  • Tumor Microenvironment (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: